Month: June 2019

The success of precision medicine and All of Us Research requires a public health perspective

“The new US precision medicine initiative, including the All of Us program, has been made possible by improvement and price reduction in genome sequencing, as well as advances in multiple sectors of biotechnology. The initiative includes two components: a focus on…

Read More

New approaches to personalized medicine for asthma

The results of the Steroids in Eosinophil Negative Asthma (SIENA) trial emphasize the importance of a personalized approach to the treatment of asthma. For a given condition, there are likely many different subtypes of patients who may respond differently to different…

Read More

What is the evidence for the use of pharmacogenetic-guided treatment for ADHD?

It has come to our attention that pharmacogenetic tests for drugs used for the treatment of ADHD and analgesics have been removed by other pharmacogenetic platforms. We believe that these actions are appropriate given the low levels of evidence for many…

Read More